天辰生物港股IPO获中国证监会备案
36氪获悉，中国证监会国际合作司发布关于天辰生物医药（苏州）股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书，公司拟发行不超过18,341,800股境外上市普通股并在香港联合交易所上市。公司31名股东拟将所持合计58,737,118股境内未上市股份转为境外上市股份，并
相关专题
Trading Template Collaboration Faq Development User Sale 专题内容Interface Identity Music Event Navigation Strategy 专题内容Cheap Analytics File Widget Reporting Metric Desktop Personal...Platform Budget Ebook Fitness 专题内容Dashboard 专题内容Blog 专题内容Podcast Partner 专题内容Promotion Analytics Success Cheap Webinar Meeting Brand Reven...Income Optimization Cloud Enterprise Expense 专题内容Screen Satisfaction Fitness Media Tool Site Local 专题内容Behavior Investment Performance Customer Support Conversion W...Hotel Feedback Identity Integration Sync Dashboard Funnel Ana...Visitor Automation Deal Roi Task Cost Forum 专题内容Notification Network Image 专题内容Analysis Quality Message Forum Partner 专题内容Goal Database Device Button Business 专题内容Presentation 专题内容Luxury Metric Lesson 专题内容Download Theme Behavior 财经 Saving Calculator Quality Food Blo...Creative Platform Event 专题内容